Document is current
Any future updates will be listed below
-
Authors
Chatain, Nicolas https://orcid.org/0000-0003-4485-3120
Baumeister, Julian
Szymanski de Toledo, Marcelo A.
Wong, Dickson W. L.
Gupta, Siddharth
Pannen, Kristina
Junge, Bärbel
Brümmendorf, Tim H. https://orcid.org/0000-0002-9677-3723
Boor, Peter https://orcid.org/0000-0001-9921-4284
Koschmieder, Steffen https://orcid.org/0000-0002-1011-8171
-
Funding
Funding for this research was provided by:
Novartis | Novartis Pharma (HABL001)
- License Information
-
More Information
Article History
Received: 25 March 2024
Revised: 13 June 2024
Accepted: 17 June 2024
First Online: 21 June 2024
Competing interests
: SK received research funding from Novartis for this preclinical study, received consulting fees, honoraria, and travel/accommodation support from Novartis, and reports participation on advisory boards for Novartis. THB served as consultant/speaker for Synlab, Incyte, Merck, Novartis, Pfizer, and Roche and received research support from Novartis and Pfizer.
